NexGard and Frontpro: documented differences

Having the same active substance, afoxolaner, does not automatically make two medicines equivalent. The comparison must follow their respective summaries of product characteristics.

Compare exact products

Name, marketing authorisation holder, presentations, weight ranges, indications and dispensing conditions must be checked separately. Choosing solely on the basis of the active substance is not correct.

The name afoxolaner must be written accurately.

Indications and differences

A comparison table may contain only facts found in the current regulatory documents. Minimum age, target parasites and duration must not be generalised.

Prescription status is checked for the Italian presentation.

Responsible choice

The veterinarian assesses parasite risk and the dog’s condition; the pharmacist checks correct dispensing. The page does not rank effectiveness or value.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• European Medicines Agency — NexGard - EPAR (accessed 24/07/2026)
• European Medicines Agency — Frontpro - EPAR (accessed 24/07/2026)
• Italian Ministry of Health — Online sale of non-prescription veterinary medicines (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.